The results indicated a significant acceleration in the adherence of cells to fibronectin in response to PLA2G7 silencing (Figure 4A), mimicking the previously described ERG knock-down phenotype [3], and supporting the possibility that PLA2G7 is an important mediator of ERG oncogene in prostate cancer. This evidence concerns the gene PLA2G7 and prostate cancer.